Dextran modulates microvascular permeability: effect in isotonic and hypertonic solutions

Transport and Lymphatic Uptake of Biotherapeutics Through Subcutaneous Injection

Drug transport and uptake in the subcutaneous tissue receives increasing attention in biomechanical and pharmaceutical researches, as subcutaneous administration becomes a common approach for the delivery of biotherapeutics, such as monoclonal antibodies. In this paper, high-fidelity numerical simulations are used to investigate the mechanisms governing drug transport and absorption in the subcutaneous tissue, which is expressed as a porous medium modeled by Darcy's law. The effects of tissue properties (permeability and porosity), the injection flow rate, and the vascular permeability of lymphatic vessels on the lymphatic uptake are studied. Additionally, an empirical formula for the lymphatic uptake during the injection is developed based on the numerical results. The roles of lymphatic drainage, blood perfusion, osmotic pressure, and the drug binding to the cells and the extracellular matrix in the lymphatic uptake are systematically studied. Furthermore, the drug distribution and absorption in a multi-layered porous medium are investigated to illustrate the effect of heterogeneity of permeability, as the permeability varies over a wide range in different layers of the tissue (such as dermis, subcutaneous tissue, muscle). While the interstitial pressure plays an essential role in the mechanisms regulating the absorption of free monoclonal antibodies, the binding and metabolism of drug proteins also affect the drug absorption by reducing the total free monoclonal antibodies.

Efficacy of Dextran Solutions in Vascular Surgery

The purpose of this paper is to discuss the role and efficacy of dextran in vascular procedures using evidence-based data from the review of surgical literature. A MEDLINE search using “dextran,” “vascular surgery,” and “antiplatelet therapy” as keywords was performed for English-language articles. Further references were obtained through cross-referencing the bibliography cited in each work. Dextran is commonly used in carotid endarterectomy (CEA) patients where the embolic rate is reduced by 46%, resulting in fewer procedure-related strokes. As a prophylactic agent against thrombosis, multiple randomized studies have reported its benefit over other antithrombotic medications. Dextran is also particularly useful in “difficult” infragenicular lower extremity bypasses where artificial grafts (such as polytetrafluoroethylene [PTFE] or umbilical vein) are used in the setting of poor outflow vessels, or those with composite grafts and small-caliber venous conduits. Distal bypasses with adjunctive procedures (eg, arteriovenous fistula or anastomotic cuffs) also have a better outcome with the addition of dextran. Dextran has numerous important implications in vascular surgery, in particular with CEA patients or “difficult” infragenicular bypasses. Its effectiveness with endovascular stents remains unknown.

Hypertonic resuscitation after severe injury: is it of benefit?

There is a wealth of preclinical data suggesting potential benefit from the administration of hypertonic solutions after severe injury with hypovolemic shock, including improved tissue perfusion, improved flow through the microcirculation, and modulation of the inflammatory response, which may mitigate subsequent organ failure. However, despite these potential advantages, clinical trials of hypertonic resuscitation early after injury have failed to demonstrate significant benefit for resuscitation of hemorrhagic shock, and although there is no difference in overall mortality, there appears to be a trend toward earlier mortality among those receiving hypertonic fluids. Likewise, for TBI there are data suggesting that hypertonic fluids should support cerebral perfusion and mitigate intracranial hypertension, yet the clinical trials of early administration to these patients have also failed to show benefit. Further study is warranted in this patient population, as a longer period of hypertonicity may be required to show a clinical effect. Assessment of long-term neurologic outcome in this patient population remains the gold standard in determining benefit.

Hypertonic fluid resuscitation from subarachnoid hemorrhage in rats: A comparison between small volume resuscitation and mannitol

OBJECTIVE

Death and severe morbidity after subarachnoid hemorrhage (SAH) are mainly caused by global cerebral ischemia through increased intracranial pressure (ICP) and decreased cerebral blood flow (CBF). We have recently demonstrated neuroprotective effects of small volume resuscitation (7.5% saline in combination with 6% dextran 70) in an animal model of SAH, leading to normalization of increased ICP, reduced morphological damage and improved neurological recovery. In the present study, we compared the concept of small volume resuscitation represented by two clinically licenced hypertonic-hyperoncotic saline solutions with the routinely used hyperosmotic agent-mannitol-and investigated their effects on ICP, CBF, neurological recovery and morphological damage after SAH in rats.

METHODS

60 dextran-resistant Wistar rats were subjected to SAH by an endovascular filament. ICP, MABP (mean arterial blood pressure) and bilateral local CBF were continuously recorded. All animals were randomly assigned to four groups: (I) NaCl 0.9% (4 ml/kg bw), (II) 7.5% NaCl+6% dextran 70 (4 ml/kg bw), (III) 7.2% NaCl+HES 200,000 (4 ml/kg bw) and (IV) 20% mannitol (9.33 ml/kg bw) given 30 min after SAH. Neurological deficits were assessed on days 1, 3 and 7 after SAH. The morphological damage was evaluated on day 7 after SAH.

RESULTS

The induction of SAH resulted in an immediate ICP increase to 46.6+/-3.2 mm Hg (mean+/-S.E.M.) and 29.6+/-1.3 (mean+/-S.E.M.) mm Hg 90 min post-SAH. While a treatment with both hypertonic saline solutions (II, III) decreased ICP as well as the 20% mannitol solution, only the group treated with hypertonic saline and dextran 70 (II) showed an increase of ipsilateral CBF for 20 min after the infusion and significantly more surviving neurons in the motorcortex and caudoputamen. Mortality was reduced from 60% (I) and 73% (III and IV), respectively, to 40% in group II.

CONCLUSION

Of all hypertonic solutions investigated, small volume resuscitation with NaCl 7.5% in combination with 6% dextran 70 evolved to be most effective in terms of reducing the initial harmful sequelae of SAH, leading to lowered ICP and less morphological damage after SAH in the rat.

Analysis using a linear viscoelastic model of the in vitro osmotic kinetics of polydisperse synthetic colloids

This study clarifies the contribution to overall osmotic kinetics of colloid osmotic pressure (Pi) and the interaction of synthetic colloids with the membrane. Solutions (6%) of dextran with weight average molecular weight (MW(w)) 68 800 (DEX 70), dextran with MW(w) 40 000 (DEX 40), hydroxyethyl starch with MW(w) 70 000 (HES 70), gelatin with MW(w) 60 000 and albumin were tested. An osmotic flow cell fitted with membranes of molecular weight cutoff size 30 000 or 50 000 was used to measure time-dependent changes in Pi for each of these solutions. A linear viscoelastic model was fitted to the curve describing changes to Pi as a function of time. Values of total effective Pi for DEX 40 and DEX 70 were larger than those for HES 70, gelatin, and albumin. As an index of solute-solvent exchange rate at the membrane surface, these values were in the order DEX 40 > DEX 70, HES 70 > gelatin, albumin. The findings suggest that DEX 40 may be preferable for the temporary restoration of plasma volume because of a heightened initial osmotic force. In contrast, the osmotic force exerted by gelatin is slower to increase but is likely to be longer lasting in vivo as a result of the inhibition of gelatin from penetrating the capillary membrane due to its interaction with negatively charged groups in the endothelial glycocalyx.

Shear stress and pressure modulate saphenous vein remodeling ex vivo

Vein graft failure remains an important clinical challenge, but factors contributing to vein graft failure have not clearly been defined. We investigated the role of the mechanical environment in vein remodeling in an ex vivo perfusion system. Porcine saphenous veins were subjected to five different ex vivo hemodynamic environments, including one mimicking an arterial bypass graft, for one week in order to independently assess the effects of shear stress and pressure on vein remodeling. The extent of intimal hyperplasia decreased with culture under increasing shear stress, with veins cultured under the lowest levels of shear stress exhibiting the greatest ratio of intimal/medial area, 0.15+/-0.03, which was greater than that of fresh veins (0.06+/-0.01, p<0.05). All perfused veins displayed characteristics of both medial hypertrophy and eutrophic remodeling, with those veins cultured under elevated pressures showing greater increases in mass and area than those cultured under venous pressures. Medial area correlated with the average pressure under which veins were cultured (R2=0.95, p<0.001), with veins cultured under bypass graft conditions, which were exposed to the greatest pressure during the one week culture, exhibiting the largest medial area (1.69+/-0.15 mm2), which was significantly greater than that of fresh veins (1.08+/-0.05 mm2, p<0.05). However, pulsatility was not a necessary stimulus for medial growth, as increases in medial area were observed in culture conditions in which steady flow and pressure were present. Our results suggest that pressure and shear stress act independently to regulate vein remodeling, influencing changes in vessel size as well as the nature of the remodeling.

Albumin impacts the effects of tonicity on microvascular hydraulic permeability

BACKGROUND

An increase in tonicity shrinks endothelial cells. This cell shrinkage may open inter-endothelial gaps and allow more fluid to escape from the microvasculature. This increase in microvascular permeability is not supported by clinical studies suggesting that water is pulled into the vascular space, not lost into the interstitium. We hypothesized that albumin influences the change in trans-endothelial water movement caused by alterations in tonicity by a mechanism other than oncotic pressure.

MATERIALS AND METHODS

Hydraulic permeability (L(p)) was measured in rat mesenteric venules using the Landis micro-occlusion model. Measures of L(p) were obtained after successive perfusions with 1% albumin solution (BSA) of varying sodium chloride (NaCl) concentrations (85, 135, 185, and 235 mm) (n = 6). Additional venules were perfused with 7% NaCl followed by 7% NaCl + BSA and L(p) measured (n = 6). Units for L(p) are x10(-7) cm/sec(-1) cm/H(2)O(-1).

RESULTS

As the NaCl concentration in BSA increased from 85 mm to 235 mm, L(p) decreased from 1.93 +/- 0.41 to 0.97 +/- 0.11. Compared to results without albumin, BSA with 185 mm NaCl decreased L(p) from 3.93 +/- 0.08 to 1.25 +/- 0.18 (P = 0.04), and BSA with 235 mm NaCl decreased L(p) from 6.14 +/- 0.05 to 0.96 +/- 0.11 (P = 0.002). There was a three-fold decrease in L(p) when BSA was added to the 7% NaCl solution (P = 0.02).

CONCLUSIONS

Albumin attenuated the increase in L(p) that is associated with higher NaCl concentrations. Because this model controls for oncotic pressure, albumin may impact L(p) by a mechanism other than oncotic force. Albumin appears to stabilize the endothelial barrier during HS perfusion and prevents the loss of intravascular fluid. Appropriate albumin levels may play an important clinical role in modulating trans-endothelial fluid efflux during HS administration.

Osmotic regulation of cell function and possible clinical applications

Inflammation and immunosuppression can cause acute respiratory distress syndrome, multiple organ failure, and sepsis, all of which are lethal posttraumatic complications in trauma patients. Prevention of the inflammation and immunosuppression has been a main focus of trauma researcher for many years. Recently, hypertonic resuscitation has attracted attention as a possible therapeutic approach to counteract such deleterious immune responses in trauma patients. We have begun to understand how hypertonic fluids affect immune cell signaling, and a number of experimental and clinical studies have started to reveal valuable information on the clinical efficacy and the limitations of hypertonic resuscitation fluids. Knowledge of how osmotic cues regulate immune cell function will enable us to fully exploit the clinical potential of hypertonic resuscitation to reduce inflammatory and anergic complications in trauma patients.

FLOW MOTION IN THE INTESTINAL VILLI DURING HEMORRHAGIC SHOCK: A NEW METHOD TO CHARACTERIZE THE MICROCIRCULATORY CHANGES

Conventional parameters are often inadequate to describe the dynamic flow changes in microcirculation. We used a novel approach to characterize oscillatory flow conditions in a canine model of hemorrhagic shock. Microcirculation in the ileal mucosal villi was visualized using intravital microscopy with the orthogonal polarization spectral imaging technique. The distribution of red blood cell velocity (RBCV) was estimated from the relative time periods of observed RBCV, and the average RBCV (A-RBCV) and its SD were then computed from the first and second moments of the RBCV distribution, respectively. Hemorrhagic shock (for 60 min) was followed by resuscitation with saline, hypertonic saline-Dextran solution (HSD, 7.2% NaCl-10% Dextran, 4 mL/kg), or HSD supplemented with the selective endothelin-A receptor antagonist ETR-p1/fl peptide (100 nmol/kg), respectively. The macrohemodynamic derangement (70% decrease in cardiac index and ileal blood flow) during shock was associated with the appearance of flow motion in the villi and an enhanced endothelin-1 release. The calculated A-RBCV was decreased by 40%. At resuscitation onset, continuous flow periods were transiently seen in 33%, 40%, and 50% of the experiments after saline, HSD, and HSD + ETR p1/fl treatment, respectively. HSD with or without endothelin-A antagonist treatment resulted in an increased relative duration of high-flow periods (by 20%) and a significant, 20% to 40% rise in A-RBCV. These results demonstrate that time-wise variability of RBCV should be used for the analysis of oscillatory flow conditions. The probabilistic estimation of A-RBCV provides a quantitative basis for comparison of the effectiveness of different resuscitation or vasoactive strategies.

The impact of albumin on hydraulic permeability: comparison of isotonic and hypertonic solutions

Hypertonic saline, Dextran, and albumin have been advocated for rapid restoration of intravascular volume. The goal of this study was to define how albumin impacts the effects of hypertonic saline and Dextran on hydraulic permeability. We hypothesized that albumin would decrease the hydraulic permeability (L(p)) of isotonic and hypertonic solutions containing Dextran. Using the modified Landis micro-occlusion technique, single rat mesenteric venules were perfused with either Ringer's + 1% albumin (RA) or hypertonic saline + 1% albumin (HSA). In sequential cannulations of the venules, 1%, 2%, and 3% Dextran was added to the RA perfusion (n = 6) and the HSA perfusion (n = 6). These results were compared with similar studies completed without albumin. Albumin significantly decreased L(p) with all HS solutions studied compared with HS without albumin. Baseline L(p) measurements for RA and HSA solutions were 1.08 +/- 0.07 and 0.51 +/- 0.03, respectively. In the RA group, 2% and 3% Dextran was associated with a lower L(p) of 0.83 +/- 0.04 (P = 0.002) and 0.67 +/- 0.05 (P = 0.002), respectively. In the HSA group, 2% and 3% Dextran was associated with a lower L(p) of 0.37 +/- 0.02 (P = 0.001) and 0.32 +/- 0.02 (P < 0.0001), respectively. All values for L(p) are x 10(-7) cm x s(-1) x cmH2O(-1). Albumin maintains low hydraulic permeability levels during perfusion with hypertonic saline. In the setting of sufficient of endothelial albumin levels, hypertonic saline and Dextran may be advantageous when used for resuscitation by decreasing trans-endothelial fluid flux and augmenting intravascular volume.

Effect of hypertonic saline on microvascular permeability in the activated endothelium

INTRODUCTION

The effect of hypertonic saline (HTS) on microvascular permeability in microvessels with activated endothelial cells is unclear. We hypothesized that HTS and HTS with dextran would decrease hydraulic permeability after activation of the endothelium.

METHODS

Hydraulic permeability (L(p)) was measured in rat mesenteric venules using the modified Landis micro-occlusion technique. The effects of 185 mM HTS and HTS plus 2% dextran (HSD) were tested in the activated endothelium by measuring L(p) at baseline, after perfusion with ATP, and again after HTS (n = 6) or HSD (n = 6). ATP (10 microM) activated endothelial cells and increased L(p) 4-fold. Additional venules were used to test the effects of 135 mM NaCl (n = 6) and 235 mM (n = 6) NaCl after endothelial activation with ATP.

RESULTS

After endothelial activation with ATP, L(p) values were 6.05 +/- 1.63. Subsequent perfusion with HTS decreased L(p) to 2.05 +/- 0.52 (P = 0.01). In the HSD trails, L(p) values after ATP were 6.17 +/- 1.38. Perfusion with HSD decreased L(p) to 1.65 +/- 0.30 (P = 0.001). After endothelial activation, 135 mM NaCl had no effect on L(p); however, 185 mM NaCl decreased L(p) 3-fold and 235 mM NaCl decreased L(p) 6-fold. Units for L(p) are x10(-7) cm - s(-1). cmH(2)O(-1).

CONCLUSIONS

Both HTS and HSD decreased hydraulic permeability after endothelial activation. These findings suggest that HTS may decrease microvascular fluid loss during states of elevated microvascular leak. In addition to the ability of hypertonic solutions to withdraw intracellular water to increase plasma volume, these findings propose an endothelial barrier mechanism whereby HTS and HSD act to maintain intravascular volume.